Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Aug 1;6(8):e011311.
doi: 10.1136/bmjopen-2016-011311.

Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial

E A Stokes  1 , S Wordsworth  1 , D Bargo  2 , K Pike  3 , C A Rogers  3 , R C M Brierley  3 , G D Angelini  4 , G J Murphy  5 , B C Reeves  3 ; TITRe2 Investigators
Collaborators, Affiliations
Randomized Controlled Trial

Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial

E A Stokes et al. BMJ Open. .

Abstract

Objective: To assess the incremental cost and cost-effectiveness of a restrictive versus a liberal red blood cell transfusion threshold after cardiac surgery.

Design: A within-trial cost-effectiveness analysis with a 3-month time horizon, based on a multicentre superiority randomised controlled trial from the perspective of the National Health Service (NHS) and personal social services in the UK.

Setting: 17 specialist cardiac surgery centres in UK NHS hospitals.

Participants: 2003 patients aged >16 years undergoing non-emergency cardiac surgery with a postoperative haemoglobin of <9 g/dL.

Interventions: Restrictive (transfuse if haemoglobin <7.5 g/dL) or liberal (transfuse if haemoglobin <9 g/dL) threshold during hospitalisation after surgery.

Main outcome measures: Health-related quality of life measured using the EQ-5D-3L to calculate quality-adjusted life years (QALYs).

Results: The total costs from surgery up to 3 months were £17 945 and £18 127 in the restrictive and liberal groups (mean difference is -£182, 95% CI -£1108 to £744). The cost difference was largely attributable to the difference in the cost of red blood cells. Mean QALYs to 3 months were 0.18 in both groups (restrictive minus liberal difference is 0.0004, 95% CI -0.0037 to 0.0045). The point estimate for the base-case cost-effectiveness analysis suggested that the restrictive group was slightly more effective and slightly less costly than the liberal group and, therefore, cost-effective. However, there is great uncertainty around these results partly due to the negligible differences in QALYs gained.

Conclusions: We conclude that there is no clear difference in the cost-effectiveness of restrictive and liberal thresholds for red blood cell transfusion after cardiac surgery.

Trial registration number: ISRCTN70923932; Results.

Keywords: blood transfusion; cost-effectiveness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cost-effectiveness plane. In order that the points could be seen, only 1000 replicates were plotted (200 replicates for each of the five imputations).
See this image and copyright information in PMC

References

    1. Habib RH, Zacharias A, Schwann TA et al. . Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005;33:1749–56. 10.1097/01.CCM.0000171531.06133.B0 - DOI - PubMed
    1. Murphy GJ, Reeves BC, Rogers CA et al. . Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544–52. 10.1161/CIRCULATIONAHA.107.698977 - DOI - PubMed
    1. Karkouti K, Wijeysundera DN, Beattie WS et al. . Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008;117:478–84. 10.1161/CIRCULATIONAHA.107.718353 - DOI - PubMed
    1. Bennett-Guerrero E, Zhao Y, O'Brien SM et al. . Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010;304:1568–75. 10.1001/jama.2010.1406 - DOI - PubMed
    1. Murphy MF, Murphy GJ, Gill R et al. . National Comparative Audit of Blood Transfusion: 2011 Audit of Blood Transfusion in Adult Cardiac Surgery 2013. http://hospital.blood.co.uk/media/26859/nca-2011_use_of_blood_in_adult_c... (accessed 30 Jul 2015).

Publication types

Associated data